The Evolution of Mastectomy: From Aggressive Surgery to Nipple-Sparing

I love this question because it captures something I find genuinely encouraging about medicine: mastectomy is one of the great examples of doing less surgery and getting the same — or better — outcomes.

Over the past several decades, the way we approach mastectomy for breast cancer (and prophylactically for BRCA and other high-risk patients) has evolved dramatically. Let me walk through how we got here, what nipple-sparing mastectomy is, and who's a candidate.

Many decades ago, when women had breast cancer and needed mastectomies, the operation was aggressive in every dimension. My grandmother had one of these. The classical radical mastectomy involved removing:

• All of the breast tissue
• Most of the chest wall skin
• The nipple and areola
• Portions of the underlying pectoralis muscle

It was a disfiguring operation that produced significant chest wall deformity, lifelong functional limitations of the arm, and substantial psychological impact. It was also believed to be necessary for cure.

It turned out it wasn't.

Over many years and many studies, surgeons figured out that we could safely take less at each step and still achieve equivalent oncologic outcomes:

The first big evolution was recognizing that leaving the pectoralis muscle intact didn't worsen cancer outcomes. This was huge for:

• Function (preserving normal arm and shoulder use)
• Cosmetic result (preserved chest contour)
• Reconstruction options (the muscle was still available for implant placement)

The next step was the skin-sparing mastectomy:

• The breast tissue was removed through a smaller incision
• The majority of the breast skin was kept
• The nipple and areola were still removed during this era
• This made reconstruction look much more natural

In the last 10–15 years, we've moved into the era of nipple-sparing mastectomy (NSM):

• The breast tissue is removed
• The nipple and areola are kept intact
• The operation is typically done through a hidden incision — often in the inframammary fold
• Cancer outcomes have been shown to be equivalent, in appropriate candidates

This is genuinely a remarkable advance.

The whole reason we can do this less-aggressive version of mastectomy is that we studied it carefully and showed:

• Patients are not more likely to die of their cancer
• They are not more likely to have a recurrence
• They preserve all the cosmetic and functional benefits of keeping the skin and nipple

For BRCA and other prophylactic patients, the same applies — sparing the skin and nipple doesn't increase the risk of developing a primary cancer in the rare residual tissue.

This is one of the strongest examples in modern oncologic surgery of "less is more" when supported by rigorous study.

Because we're no longer making an incision around the nipple-areola complex, the incision options open up significantly:

We can make the incision in the breast crease, where it's well-hidden. After healing, you can't see the incision when you look at yourself in the mirror — because it's tucked up underneath the breast.

Some patients are candidates for lateral incisions (under the arm) or other discreet locations, depending on the cancer location and anatomy.

The aesthetic difference between a nipple-sparing mastectomy and the older skin-sparing version is enormous:

• You keep your own nipple
• The breast looks much more like yours
• You feel more like yourself afterward
• The visible signs of having had a mastectomy are minimal

This depends on whether you're a BRCA/prophylactic patient or a breast cancer patient.

Essentially all BRCA patients undergoing prophylactic mastectomy are candidates for nipple-sparing mastectomy if they want one. Even patients with:

• Droopy breasts (ptosis)
• Larger breasts
• A history of prior breast surgery (like a breast lift)

…can typically still have nipple-sparing surgery — though larger or droopier breasts do come with a slightly higher risk of nipple necrosis because of the longer blood-supply distance.

For patients with significant ptosis, some surgical teams will stage the surgery (lift first, mastectomy later) to optimize nipple survival, while others do it as a combined operation. The trade-offs of doing it staged vs. simultaneous are worth a separate conversation.

For breast cancer patients, candidacy for nipple-sparing mastectomy depends largely on:

• Where the tumor is located
• How close it is to the nipple
• Imaging characteristics of the tumor
• Tumor size and biology

In my practice, it's an option for most patients — but not all. Tumors that are too close to the nipple may make nipple-sparing inadvisable due to oncologic concerns.

This is exactly why vetting your breast surgeon's skill and philosophy matters so much. Some surgeons "don't believe in" nipple-sparing mastectomy — and that's usually not a real medical reason. If you're otherwise a candidate, you deserve a surgeon willing to offer the option.

Beyond the aesthetic improvement, nipple-sparing mastectomy lets you keep:

• Your own nipple-areola complex (rather than reconstructed nipples added in a separate later procedure)
• More natural shape and projection of the breast
• A sense of bodily continuity through cancer treatment
• A less visible reminder of having had a mastectomy

The psychological benefit is real, particularly for younger patients and for patients undergoing prophylactic mastectomy who weren't even sick to begin with.

Nipple-sparing mastectomy isn't without considerations:

• Sensation to the nipple is usually significantly reduced or absent (covered in detail in my post on mastectomy sensation)
• There's a risk of nipple necrosis if the blood supply doesn't survive the surgery (more common in larger or droopier breasts)
• Some patients still need resensation procedures to restore sensation
• Surveillance imaging is still important afterward — having a "real" nipple doesn't change that

But the benefits in cosmetic and emotional outcomes are substantial, and the cancer outcomes are equivalent.

I want to close with something I think is genuinely beautiful about modern medicine.

We used to do bigger surgeries because we believed they were necessary for cure. We were wrong. Less surgery, done well, in carefully selected patients, achieves the same oncologic outcome — and produces dramatically better quality of life.

That progression — from radical mastectomy to muscle-sparing to skin-sparing to nipple-sparing — is what evidence-based medicine looks like when it works. Each generation of surgeons asked, "Do we really need this part?" And when the answer turned out to be no, we stopped doing it.

For breast cancer and BRCA patients today, this means:

• You can have the cancer addressed effectively
• You can preserve your nipples
• You can preserve your muscle
• You can preserve most of your skin
• You can have hidden incisions
• You can have excellent reconstruction
• You can come through this looking and feeling much more like yourself

That's a tremendous gift compared to what my grandmother went through.

Mastectomy has evolved dramatically over the last several decades — from radical operations that removed muscle, skin, and the nipple-areola complex, to modern nipple-sparing mastectomies that preserve the nipple, the skin, and (often) the option of hidden incisions.

The reason we can do this is that we studied it carefully and showed that less aggressive surgery delivers equivalent cancer outcomes.

If you're facing a mastectomy:

• BRCA / prophylactic patients are almost always candidates for nipple-sparing
• Breast cancer patients are candidates depending on tumor location and biology
• Most patients in my practice have the option

If your surgeon "doesn't believe in" nipple-sparing mastectomy without a specific medical reason for your case, get another opinion. This is well-established and safe in 2026 — and you deserve the option of preserving your own anatomy through cancer treatment.